31 results match your criteria: "Hospitalet de LL[Affiliation]"
Res Sq
February 2024
Universidad de Salamanca-CSIC. IBSAL.
Post-pregnancy breast cancer often carries a poor prognosis, posing a major clinical challenge. The increasing trend of later-life pregnancies exacerbates this risk, highlighting the need for effective chemoprevention strategies. Current options, limited to selective estrogen receptor modulators, aromatase inhibitors, or surgical procedures, offer limited efficacy and considerable side effects.
View Article and Find Full Text PDFIntroduction: For more than a decade, after the ECTRIMS Congress, Spain has hosted the Post-ECTRIMS meeting, where neurologists with expertise in multiple sclerosis (MS) meet to review the new developments presented at the ECTRIMS.
Aim: This article, published in two parts, summarises the presentations of the post-ECTRIMS meeting, held online on 16 and 17 October 2020.
Development: This second part highlights the importance of gender and age in understanding the pathology of the disease and optimising its management.
Introduction: For more than a decade, following the ECTRIMS Congress, the Post-ECTRIMS Meeting has been held in Spain, where neurologists with expertise in multiple sclerosis (MS) from all over the country meet to review the most relevant latest developments presented at the ECTRIMS congress (on this occasion held together with ACTRIMS).
Aim: This article, published in two parts, summarises the presentations that took place at the Post-ECTRIMS Meeting, held online on 16 and 17 October 2020.
Development: This first part includes the latest results regarding the impact of the environment and lifestyle on risk of MS and its clinical course, and the role of epigenetics and genetic factors on these processes.
J Clin Med
March 2021
Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna, Hospital Universitario de Bellvitge-IDIBELL, 08907 Barcelona, Spain.
Trials
February 2021
Intensive Care Department, Hospital Universitari de Bellvitge, L'Hospitalet de LL., Barcelona, Spain.
Cardiol J
September 2021
Hospital Universitario de Bellvitge, Universidad de Barcelona, IDIBELL, Hospitalet de Ll, Spain.
Background: Mechanical complications represent an important cause of mortality in myocardial infarction (MI) patients. This is a nationwide study performed to evaluate possible changes in epidemiology or prognosis of these complications with current available strategies.
Methods: Information was obtained from the minimum basis data set of the Spanish National Health System, including all hospitalizations for acute myocardial infarction (AMI) from 2010 to 2015.
Rev Neurol
June 2020
Hospital de Cruces, Baracaldo, España.
Rev Neurol
May 2020
Hospital de Cruces, Baracaldo, España.
Introduction: Like every year, after the ECTRIMS Congress, renowned Spanish neurologists who are experts in multiple sclerosis presented the main novelties in research in this field at the Post-ECTRIMS Meeting.
Aim: To summarise the content presented at the 12th edition of the Post-ECTRIMS Meeting, which took place in September 2019 in Sevilla and is presented in two parts.
Development: This first part addresses the latest studies on vitamin D deficiency and the discrepancies that currently exist regarding its treatment.
Rev Neurol
March 2020
Hospital Universitari de Bellvitge-ICO L'Hospitalet (IDIBELL) , Hospitalet de Ll., España.
Rev Neurol
July 2019
Hospital Universitari de Bellvitge, Hospitalet de Ll., Espana.
Introduction: The care of patients with Alzheimer's disease increases the burden and depression of the main caregiver, although the relationship between the two is not clearly defined.
Aims: To explore the factors associated with depressive symptomatology and burden in the main caregiver and to apply a model of structural equations to identify the relationship between them.
Subjects And Methods: The sample consisted of 127 family caregivers of people with Alzheimer's disease, with a follow-up of 24 months.
Rev Neurol
June 2019
Hospital de Cruces, Baracaldo, Espana.
The Post-ECTRIMS Meeting was held for the eleventh consecutive year in October 2018 in Madrid, with the aim of analysing the advances made in multiple sclerosis that were highlighted at the latest ECTRIMS annual congress. Based on the issues discussed at this meeting, attended by the nation's foremost opinion leaders on multiple sclerosis, two review articles are presented. This second part includes the growing body of evidence confirming the safety of exposure to disease-modifying treatments in women planning a pregnancy, and the beneficial effect of breastfeeding, provided that the disease is not very active.
View Article and Find Full Text PDFRev Neurol
May 2019
Hospital de Cruces, Baracaldo, Espana.
The Post-ECTRIMS Meeting is an emblematic event in Spain which seeks to review and disseminate the main advances in multiple sclerosis presented at the ECTRIMS annual congress. In October 2018, the eleventh Post-ECTRIMS meeting was held in Madrid and was attended by the country's leading experts in multiple sclerosis. As a result of this meeting, we present two articles which outline the most interesting novelties discussed there.
View Article and Find Full Text PDFRev Neurol
February 2019
Hospital Universitari de Bellvitge, Hospitalet de Ll., Espana.
Rev Neurol
December 2016
Hospital Universitario de la Princesa, 28006 Madrid, Espana.
Expert Rev Clin Immunol
December 2014
Hospital Universitari de Bellvitge, University of Barcelona, Feixa Llarga, s/n, 08907 Hospitalet de Ll., Catalunya, Barcelona, Spain.
Tacrolimus is a cornerstone of the immunosuppression regimen for prevention of allograft rejection in kidney and liver transplantations, with efficacy proven in many clinical trials. The currently available and extensively used tacrolimus formulations are flawed by large inter- and intra-individual variability, low bioavailability, wide peak-to-trough fluctuations and a narrow therapeutic index. Drug delivery technology can significantly impact the pharmacologic action of a drug, influencing its pharmacokinetic and subsequent therapeutic profile.
View Article and Find Full Text PDFJ Clin Pathol
October 2009
Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Program, Institut Català d' Oncologia, IDIBELL, L' Hospitalet de Ll, Barcelona, Spain.
Cancer Epidemiol Biomarkers Prev
July 2007
Epidemiology and Cancer Registry Unit, Institut Català d' Oncologia, Gran Via km 2.7, 08907 L' Hospitalet de Ll., Barcelona, Spain.
Palliat Med
January 2007
Geriatric Unit, Internal Medicine Service, Hospital Universitari de Bellvitge, L'Hospitalet de LL, Barcelona, Spain.
Rev Neurol
May 2005
Servicio de Neurología, Hospital de Bellvitge, L'Hospitalet de Ll., Barcelona, Spain.
Rev Neurol
September 2004
Servicio de Neurología, Hospital Universitari de Bellvitge, Universitat de Barcelona, L'Hospitalet de Ll., Barcelona, Spain.
Int J Cancer
September 2003
International Agency for Research on Cancer, Lyon, France.
Our aim was to estimate the prevalence of mutations in the BRCA1 and BRCA2 genes among unselected incident cases of breast cancer in young women. We identified 158 incident breast cancer cases diagnosed before age 46 years in predefined geographic areas in Girona and Tarragona, Spain, during 1995-1997. Of these, 136 (86%) provided information on family history of cancer and were screened for BRCA1 and BRCA2 mutations.
View Article and Find Full Text PDFRev Neurol
March 2004
Servicio de Neurología, Ciutat Sanitària i Universitària de Bellvitge, L 'Hospitalet de Ll., Barcelona, España.
Virus Res
November 2002
Department of Epidemiology and Cancer Registry, Catalan Institute of Oncology, Gran Via km 2.7, 08907 Hospitalet de Ll, Barcelona, Spain.
Heart
August 2002
Geriatric Unit, Internal Medicine Service, CSU de Bellvitge. L'Hospitalet de LL, Barcelona, Spain.
J Clin Pediatr Dent
May 2001
Dental School, University of Barcelona, Pabellón de Gobierno, 2a planta, Feixa Llarga s/n, 08907 Hospitalet de Ll., Barcelona, Spain.